Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
They found a new molecule named lariocidin —a potential new antibiotic with the power to kill some of the world’s most ...
Nanogels improve drug delivery with controlled release and targeted systems, utilizing pH responsiveness and hybrid materials for enhanced therapeutic efficacy.
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug ...
Scientists have taken an important step toward the development of a potential new treatment for treating Shiga ...
The effect of saccharin on the microbiome has received much attention, but its impact on pathogenic bacterial species is less ...
Global Antimicrobial Resistance Market is valued approximately at USD 4.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast period 2024-2032.